These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 25668771)

  • 1. Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer's disease.
    Rotman M; Welling MM; Bunschoten A; de Backer ME; Rip J; Nabuurs RJ; Gaillard PJ; van Buchem MA; van der Maarel SM; van der Weerd L
    J Control Release; 2015 Apr; 203():40-50. PubMed ID: 25668771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP/PS1 mice but does not increase brain uptake.
    Rotman M; Welling MM; van den Boogaard ML; Moursel LG; van der Graaf LM; van Buchem MA; van der Maarel SM; van der Weerd L
    Nucl Med Biol; 2015 Aug; 42(8):695-702. PubMed ID: 25960433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted brain delivery of methotrexate by glutathione PEGylated liposomes: How can the formulation make a difference?
    Hu Y; Gaillard PJ; de Lange ECM; Hammarlund-Udenaes M
    Eur J Pharm Biopharm; 2019 Jun; 139():197-204. PubMed ID: 30951819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced brain delivery of the opioid peptide DAMGO in glutathione pegylated liposomes: a microdialysis study.
    Lindqvist A; Rip J; Gaillard PJ; Björkman S; Hammarlund-Udenaes M
    Mol Pharm; 2013 May; 10(5):1533-41. PubMed ID: 22934681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo detection of amyloid-β deposits using heavy chain antibody fragments in a transgenic mouse model for Alzheimer's disease.
    Nabuurs RJ; Rutgers KS; Welling MM; Metaxas A; de Backer ME; Rotman M; Bacskai BJ; van Buchem MA; van der Maarel SM; van der Weerd L
    PLoS One; 2012; 7(6):e38284. PubMed ID: 22675537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of single domain anti-transferrin receptor antibodies for blood-brain barrier transcytosis using a neurotensin based assay and histological assessment of target engagement in a mouse model of Alzheimer's related amyloid-beta pathology.
    Su S; Esparza TJ; Brody DL
    PLoS One; 2022; 17(10):e0276107. PubMed ID: 36256604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmigration of beta amyloid specific heavy chain antibody fragments across the in vitro blood-brain barrier.
    Rutgers KS; Nabuurs RJ; van den Berg SA; Schenk GJ; Rotman M; Verrips CT; van Duinen SG; Maat-Schieman ML; van Buchem MA; de Boer AG; van der Maarel SM
    Neuroscience; 2011 Sep; 190():37-42. PubMed ID: 21683126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
    Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
    J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of glutathione conjugation on the transcellular transport process of PEGylated liposomes across the blood brain barrier.
    Reginald-Opara JN; Tang M; Svirskis D; Chamley L; Wu Z
    Int J Pharm; 2022 Oct; 626():122152. PubMed ID: 36055442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
    Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
    Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle.
    Niewoehner J; Bohrmann B; Collin L; Urich E; Sade H; Maier P; Rueger P; Stracke JO; Lau W; Tissot AC; Loetscher H; Ghosh A; Freskgård PO
    Neuron; 2014 Jan; 81(1):49-60. PubMed ID: 24411731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
    Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation.
    Gaillard PJ; Appeldoorn CC; Rip J; Dorland R; van der Pol SM; Kooij G; de Vries HE; Reijerkerk A
    J Control Release; 2012 Dec; 164(3):364-9. PubMed ID: 22732475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Izco M; Martínez P; Corrales A; Fandos N; García S; Insua D; Montañes M; Pérez-Grijalba V; Rueda N; Vidal V; Martínez-Cué C; Pesini P; Sarasa M
    Neuroscience; 2014 Mar; 263():269-79. PubMed ID: 24447596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional LUV liposomes decorated for BBB and amyloid targeting - B. In vivo brain targeting potential in wild-type and APP/PS1 mice.
    Papadia K; Giannou AD; Markoutsa E; Bigot C; Vanhoute G; Mourtas S; Van der Linded A; Stathopoulos GT; Antimisiaris SG
    Eur J Pharm Sci; 2017 May; 102():180-187. PubMed ID: 28285172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single domain antibody-scFv conjugate targeting amyloid β and TfR penetrates the blood-brain barrier and interacts with amyloid β.
    Faresjö R; Sjöström EO; Dallas T; Berglund MM; Eriksson J; Sehlin D; Syvänen S
    MAbs; 2024; 16(1):2410968. PubMed ID: 39358860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease.
    Mourtas S; Lazar AN; Markoutsa E; Duyckaerts C; Antimisiaris SG
    Eur J Med Chem; 2014 Jun; 80():175-83. PubMed ID: 24780594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood-brain barrier in rats.
    Rip J; Chen L; Hartman R; van den Heuvel A; Reijerkerk A; van Kregten J; van der Boom B; Appeldoorn C; de Boer M; Maussang D; de Lange EC; Gaillard PJ
    J Drug Target; 2014 Jun; 22(5):460-7. PubMed ID: 24524555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment.
    Banks WA; Farr SA; Morley JE; Wolf KM; Geylis V; Steinitz M
    Exp Neurol; 2007 Aug; 206(2):248-56. PubMed ID: 17582399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve Growth Factor Gene Delivery across the Blood-Brain Barrier to Reduce Beta Amyloid Accumulation in AD Mice.
    Rodrigues BDS; Kanekiyo T; Singh J
    Mol Pharm; 2020 Jun; 17(6):2054-2063. PubMed ID: 32315185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.